Peripheral Vascular Disease
📧 Sign up to get email alerts when something new happens for Peripheral Vascular Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2013-08-14Clinical Trial Update: Radiofrequency for the Treatment of Peripheral Vascular Occlusive Disease of the Lower Extremities [Phase 2, Phase 3]
A Phase 2/3 trial evaluating radiofrequency treatment for peripheral vascular occlusive disease of the lower extremities has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-10-31Clinical Trial Update: Evaluation of Surgical Risk in Elderly Patients Submitted to Elective Surgery
A clinical trial evaluating surgical risk in elderly patients undergoing elective surgery has been withdrawn.
-
EMA withdrawal · 2011-02-28EMA Withdrawn: Clopidogrel 1A Pharma (clopidogrel) — Acino Pharma GmbH
EMA has withdrawn Clopidogrel 1A Pharma (clopidogrel) from Acino Pharma GmbH.
-
EMA withdrawal · 2009-04-23EMA Application withdrawn: Clopidogrel Teva Pharma (clopidogrel) — Teva Pharma B.V.
The EMA application for Clopidogrel Teva Pharma (clopidogrel) has been withdrawn.